Related Experiment Video
Updated: Jan 21, 2026
08:32
Development and Assessment of Intracellular Infection Models for Staphylococcus aureus
Published on: January 17, 2025
1.2K
Purulent bacterial pericarditis from Staphylococcus aureus.
Adam Kaye1,2, Gregory A Peters1,2, Joshua W Joseph1,2
1Department of Emergency Medicine Beth Israel Deaconess Medical Center Boston Massachusetts.
Clinical Case Reports
|July 31, 2019
Summary
Purulent pericarditis, a rare infection of the heart sac, requires prompt diagnosis using imaging and lab tests. Early treatment with antibiotics and source control is crucial for patient recovery.
Area of Science:
- Infectious Diseases
- Cardiology
Background:
- Purulent pericarditis is an uncommon but serious infection affecting the pericardium.
- Its incidence has decreased with the advent of antibiotics.
Observation:
- Diagnosis relies on identifying pericardial effusions.
- Radiographic and laboratory findings suggestive of infection are key.
- Pericardial fluid culture serves as the definitive diagnostic method.
Findings:
- Suspect purulent pericarditis in patients presenting with pericardial effusions and infectious signs.
- Prompt identification of the causative pathogen via fluid culture is essential.
Implications:
- Early source control and appropriate antibiotic therapy are critical for managing purulent pericarditis.
- Aggressive treatment strategies can improve outcomes in this rare condition.
Related Concept Videos
01:22Pericarditis I: Introduction
356
Pericarditis is defined as the inflammation of the pericardium, the thin, sac-like membrane surrounding the heart. This condition can cause significant chest pain and other symptoms, often necessitating medical intervention. The pericardium has two layers: the inner visceral layer and the outer parietal layer, separated by a small amount of fluid that reduces friction during heartbeats.Types of PericarditisPericarditis can be classified into several types based on the duration and nature of the...
356
01:25Pericarditis IV: Nursing Management
335
Pericarditis, an inflammation of the pericardium, necessitates diligent nursing management to ensure effective patient care and recovery. The initial step in managing pericarditis is a comprehensive patient medical assessment.The patient reports chest pain aggravated by breathing, coughing, and swallowing, which worsens when lying supine. The pain often improves when sitting up and leaning forward. Additional symptoms may include fever, malaise, and, in severe cases, signs of heart failure.
335
01:17Pericarditis III: Medical Management
321
The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...
321
01:19Pericarditis II: Clinical Features and Diagnostic Tests
294
Pericarditis is distinguished by inflammation of the pericardium, the fibrous sac that encases the heart. It can be acute, lasting less than six weeks, or chronic, persisting for over three months. Understanding its clinical manifestations and diagnostic findings is crucial for timely and effective management.Clinical ManifestationsWhile pericarditis can be asymptomatic, it usually presents with characteristic symptoms such as:Chest Pain: The most characteristic symptom of pericarditis is chest...
294
01:30Bacterial Signaling
40.1K
Bacterial signaling can occur within bacteria (intracellular) or between bacteria (intercellular). At times, a group of bacteria behaves like a community. To achieve this, they engage in quorum sensing, the perception of higher cell density that causes changes in gene expression. Quorum sensing involves both extracellular and intracellular signaling. The signaling cascade starts with a molecule called an autoinducer (AI). Individual bacteria produce AIs that move out of the bacterial cell...
40.1K
01:33Bacterial Transformation
59.5K
In 1928, bacteriologist Frederick Griffith worked on a vaccine for pneumonia, which is caused by Streptococcus pneumoniae bacteria. Griffith studied two pneumonia strains in mice: one pathogenic and one non-pathogenic. Only the pathogenic strain killed host mice.
Griffith made an unexpected discovery when he killed the pathogenic strain and mixed its remains with the live, non-pathogenic strain. Not only did the mixture kill host mice, but it also contained living pathogenic bacteria that...
Griffith made an unexpected discovery when he killed the pathogenic strain and mixed its remains with the live, non-pathogenic strain. Not only did the mixture kill host mice, but it also contained living pathogenic bacteria that...
59.5K